137 related articles for article (PubMed ID: 11042561)
1. p27(Kip1) loss does not predict survival in patients with advanced gastric carcinoma.
Feakins RM; Mulcahy HE; Quaglia A; Jawhari A; Zhang Z; Patchett SE
Cancer; 2000 Oct; 89(8):1684-91. PubMed ID: 11042561
[TBL] [Abstract][Full Text] [Related]
2. p27 Kip1 expression is reduced in pancreatic carcinoma but has limited prognostic value.
Feakins RM; Ghaffar AH
Hum Pathol; 2003 Apr; 34(4):385-90. PubMed ID: 12733121
[TBL] [Abstract][Full Text] [Related]
3. Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival.
Del Pizzo JJ; Borkowski A; Jacobs SC; Kyprianou N
Am J Pathol; 1999 Oct; 155(4):1129-36. PubMed ID: 10514396
[TBL] [Abstract][Full Text] [Related]
4. Low level of p27(Kip1) protein expression in gastric adenocarcinoma is associated with disease progression and poor outcome.
Nitti D; Belluco C; Mammano E; Marchet A; Ambrosi A; Mencarelli R; Segato P; Lise M
J Surg Oncol; 2002 Dec; 81(4):167-75; discussion 175-6. PubMed ID: 12451619
[TBL] [Abstract][Full Text] [Related]
5. Cyclin-dependent kinase inhibitor P27(KIP1) is expressed preferentially in early stages of urothelial carcinoma.
Franke KH; Miklosi M; Goebell P; Clasen S; Steinhoff C; Anastasiadis AG; Gerharz C; Schulz WA
Urology; 2000 Oct; 56(4):689-95. PubMed ID: 11018640
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients.
Al-Moundhri MS; Nirmala V; Al-Hadabi I; Al-Mawaly K; Burney I; Al-Nabhani M; Thomas V; Ganguly SS; Grant C
J Surg Oncol; 2005 Sep; 91(4):243-52. PubMed ID: 16121348
[TBL] [Abstract][Full Text] [Related]
7. Combined examination of p27(Kip1), p21(Waf1/Cip1) and p53 expression allows precise estimation of prognosis in patients with gastric carcinoma.
Liu XP; Kawauchi S; Oga A; Suehiro Y; Tsushimi K; Tsushimi M; Sasaki K
Histopathology; 2001 Dec; 39(6):603-10. PubMed ID: 11903579
[TBL] [Abstract][Full Text] [Related]
8. Decreased p27(Kip1) expression and cyclin D1 overexpression, alone and in combination, influence recurrence and survival of patients with resectable extrahepatic bile duct carcinoma.
Hui AM; Cui X; Makuuchi M; Li X; Shi YZ; Takayama T
Hepatology; 1999 Nov; 30(5):1167-73. PubMed ID: 10534337
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of p27 in gastric cancer.
Wiksten JP; Lundin J; Nordling S; Kokkola A; von Boguslawski K; Haglund C
Oncology; 2002; 63(2):180-4. PubMed ID: 12239454
[TBL] [Abstract][Full Text] [Related]
10. Low expression of p27(Kip1) in advanced mucoepidermoid carcinomas of head and neck.
Choi CS; Choi G; Jung KY; Choi JO; Chae YS
Head Neck; 2001 Apr; 23(4):292-7. PubMed ID: 11400230
[TBL] [Abstract][Full Text] [Related]
11. Loss of p27(KIP1) expression predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Shamma A; Doki Y; Tsujinaka T; Shiozaki H; Inoue M; Yano M; Kawanishi K; Monden M
Oncology; 2000 Feb; 58(2):152-8. PubMed ID: 10705242
[TBL] [Abstract][Full Text] [Related]
12. Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer.
Chappuis PO; Kapusta L; Bégin LR; Wong N; Brunet JS; Narod SA; Slingerland J; Foulkes WD
J Clin Oncol; 2000 Dec; 18(24):4045-52. PubMed ID: 11118465
[TBL] [Abstract][Full Text] [Related]
13. Cyclin-dependent kinase inhibitor p27(Kip1) expression in transitional cell carcinoma of renal pelvis and ureter.
Masuda M; Takano Y; Iki M; Makiyama K; Ikeda I; Noguchi S; Hasegawa Y; Hosaka M
Cancer Lett; 2000 Mar; 150(2):183-9. PubMed ID: 10704741
[TBL] [Abstract][Full Text] [Related]
14. p27(Kip1) expression in normal epithelia, precancerous lesions, and carcinomas of the gallbladder: association with cancer progression and prognosis.
Hui AM; Li X; Shi YZ; Torzilli G; Takayama T; Makuuchi M
Hepatology; 2000 May; 31(5):1068-72. PubMed ID: 10796881
[TBL] [Abstract][Full Text] [Related]
15. Reduced expression of p27(Kip1) protein in relation to salivary adenoid cystic carcinoma metastasis.
Takata T; Kudo Y; Zhao M; Ogawa I; Miyauchi M; Sato S; Cheng J; Nikai H
Cancer; 1999 Sep; 86(6):928-35. PubMed ID: 10491517
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of the cyclin-dependent kinase inhibitor p27Kip1 in gastric cancer.
Müller W; Grabsch H; Takeno S; Noguchi T; Hommel G; Gabbert HE
Anticancer Res; 2000; 20(3A):1787-92. PubMed ID: 10928108
[TBL] [Abstract][Full Text] [Related]
17. Impact of the expression of cyclin-dependent kinase inhibitor p27Kip1 and apoptosis in tumor cells on the overall survival of patients with non-early stage gastric carcinoma.
Ohtani M; Isozaki H; Fujii K; Nomura E; Niki M; Mabuchi H; Nishiguchi K; Toyoda M; Ishibashi T; Tanigawa N
Cancer; 1999 Apr; 85(8):1711-8. PubMed ID: 10223564
[TBL] [Abstract][Full Text] [Related]
18. Expression of p27(Kip1) protein in transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Kawai T; Aida S; Kasamatsu H; Aurues T; Ikeda T
Mod Pathol; 2001 May; 14(5):371-6. PubMed ID: 11353044
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of the cell-cycle inhibitor p27Kip1 is associated with progression and lymph node metastasis of gastric carcinoma.
Kim DH; Lee HI; Nam ES; Shin HS; Sohn JH; Park CH; Yoon DS; Song SY; Park YE
Histopathology; 2000 Mar; 36(3):245-51. PubMed ID: 10692028
[TBL] [Abstract][Full Text] [Related]
20. p27(kip1) expression in breast carcinomas: an immunohistochemical study on 512 patients with long-term follow-up.
Barbareschi M; van Tinteren H; Mauri FA; Veronese S; Peterse H; Maisonneuve P; Caffo O; Scaioli M; Doglioni C; Galligioni E; Dalla Palma P; Michalides R
Int J Cancer; 2000 May; 89(3):236-41. PubMed ID: 10861499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
